Phase III study of intraperitoneal cisplatin-intravenous cyclophosphamide versus intravenous cisplatin-intravenous cyclophosphamide in patients with optimal disease stage III ovarian cancer: a SWOG-GOG-ECOG Intergroup study
暂无分享,去创建一个
D. Alberts | R. O’Toole | R. Alvarez | M. Rothenberg | S. Williams | W. Hoskins | D. Clarke‐Pearson | P. Liu | E. Hannigan | V. Malviya | M. Adelson | B. Dubeshter | J. A. Young | J. O'Sullivan | E. W. Franklin | D. Sparks | J. Quade